Primary open angle glaucoma due to T377M MYOC: Population mapping of a Greek founder mutation in Northwestern Greece.
BACKGROUND
Mutations in the MYOC gene have been shown to explain 5% of unrelated primary open angle glaucoma (POAG) in different populations. In particular, the T377M MYOC mutation has arisen at least three separate times in history, in Great Britain, India, and Greece. The purpose of this study is to investigate the distribution of the mutation among different population groups in the northwestern region of Greece.


METHODS
We explored the distribution of the "Greek" T377M founder mutation in the Epirus region in Northwestern Greece, which could be its origin. Genotyping was performed in POAG cases and controls by PCR amplification of the MYOC gene, followed by digestion with restriction enzyme. Statistical analyses were performed by an exact test, the Kaplan-Meier method and the t-test.


RESULTS
In the isolated Chrysovitsa village in the Pindus Mountains, a large POAG family demonstrated the T377M mutation in 20 of 66 family members while no controls from the Epirus region (n = 124) carried this mutation (P < 0.001). Among other POAG cases from Epirus, 2 out of 14 familial cases and 1 out of 80 sporadic cases showed the mutation (P = 0.057). The probability of POAG diagnosis with advancing age among mutation carriers was 23% at age 40, and reached 100% at age 75. POAG patients with the T377M mutation were diagnosed at a mean age of 51 years (SD +/- 13.9), which is younger than the sporadic or familial POAG cases: 63.1 (SD +/- 11) and 66.8 (SD +/- 9.8) years, respectively.


CONCLUSIONS
The T377M mutation was found in high proportion in members of the Chrysovitsa family (30.3%), in lower proportion in familial POAG cases (14.2%) and seems rare in sporadic POAG cases (1.2%), while no controls (0%) from the Epirus region carried the mutation. Historical and geographical data may explain the distribution of this mutation within Greece and worldwide.
Kitsos
George
G
Department of Ophthalmology, University of Ioannina, School of Medicine, Ioannina, Greece. gkitsos@cc.uoi.gr
Petrou
Zacharias
Z
Grigoriadou
Maria
M
Samples
John R
JR
Hewitt
Alex W
AW
Kokotas
Haris
H
Giannoulia-Karantana
Aglaia
A
Mackey
David A
DA
Wirtz
Mary K
MK
Moschou
Marilita
M
Ioannidis
John P A
JP
Petersen
Michael B
MB
Arch Ophthalmol. 1998 Jun;116(6):793-7
9639450
Nat Genet. 1993 May;4(1):47-50
8513321
Am J Hum Genet. 1998 Nov;63(5):1549-52
9792882
Nucleic Acids Res. 1988 Feb 11;16(3):1215
3344216
Invest Ophthalmol Vis Sci. 2005 Aug;46(8):2662-70
16043835
Br J Ophthalmol. 2008 Nov;92(11):1567-8
18952665
Am J Med Genet. 1998 Apr 13;76(5):438-45
9556305
Eur J Hum Genet. 2001 Jun;9(6):452-7
11436127
Am J Ophthalmol. 2005 Oct;140(4):760-2
16226543
Mol Vis. 2007 Mar 28;13:487-92
17417609
N Engl J Med. 1998 Apr 9;338(15):1022-7
9535666
Ophthalmology. 1996 Jul;103(7):1035-40
8684791
Mol Vis. 2003 Nov 14;9:606-14
14627955
Mol Vis. 2008 Apr 25;14:774-81
18449353
Am J Hum Genet. 1997 Feb;60(2):296-304
9012402
Science. 1997 Jan 31;275(5300):668-70
9005853
Am J Hum Genet. 1995 Jun;56(6):1431-42
7762566
J Med Genet. 1996 Dec;33(12):1043-4
9004141
Ophthalmic Genet. 2005 Mar;26(1):17-23
15823921
Ophthalmic Genet. 2003 Sep;24(3):153-60
12868033
Hum Mol Genet. 2002 Sep 1;11(18):2077-90
12189160
J Fr Ophtalmol. 1988;11(12):859-64
3253316
Invest Ophthalmol Vis Sci. 2006 Feb;47(2):620-5
16431959
Arch Ophthalmol. 2003 Aug;121(8):1172-80
12912696
Invest Ophthalmol Vis Sci. 1998 Nov;39(12):2288-95
9804137
Hum Mutat. 2008 Feb;29(2):207-11
17966125
Arch Ophthalmol. 1994 Jan;112(1):69-73
8285897
Ophthalmology. 1994 Nov;101(11):1851-5
7800368
Am J Ophthalmol. 2007 Oct;144(4):511-9
17893012
Am J Ophthalmol. 2000 Aug;130(2):165-77
11004290